Difference between revisions of "Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5 (Q9817)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Cancer Immunol. Immunother., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): 576-582, #quickstatements; #temporary_batch_1590074839150) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Property / Volume | |||
| + | 52 | ||
| Property / Volume: 52 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Safety biodistribution pharmacokinetics and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck (English) | ||
| Property / title: Safety biodistribution pharmacokinetics and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 576-582 | ||
| Property / Page(s): 576-582 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Colnot DR
0 references
2003
0 references
Cancer Immunol. Immunother.
0 references
52
0 references
Safety biodistribution pharmacokinetics and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck (English)
0 references
576-582
0 references
